Nico Corp. said it won 501(k) clearance from the FDA for its Myriad Novus resection tool. Indianapolis-based Nico said the device combines its Myriad resection tool with a xenon light and tissue-harvesting capabilities during intracerebral hemorrhage clot removal and subcortical tumor resection. “The Novus represents the next generation of Nico’s flagship product the Myriad,” president […]
Nico Corp. said today that it raised nearly $13 million in a Series B round from a group of existing backers for its line of neurosurgery devices. Indianapolis-based Nico said the $12.5 million round is earmarked for new product development and commercialization, clinical and economic studies, growing its sales and clinical teams, and expanding its footprint […]
Nico Corp said today it won CE Mark approval in the European Union for its BrainPath neurosurgery access device. The BrainPath system uses a shunt and specially designed instrumentation to give surgeons access to the subcortical section of the brain. “Gaining CE Mark approval for BrainPath is our first step in answering increasing global interest in a […]
Nico Corp said today it enrolled the 1st patient in the Enrich clinical trial which aims to explore the use of its BrainPath Approach for treating intracerebral hemorrhages. The trial will examine the procedural safety as well as economic and functional benefit of early surgical removal of intracerebral hemorrhages using its BrainPath Approach system. “Our initial clinical results […]
Nico Corp today released data from 2 recently published studies which utilized its BrainPath Approach to treat hemorrhagic stroke, touting a 95% clot reduction and no mortalities associated with the device. The BrainPath system uses a shunt and specially designed instrumentation to give surgeons access to the subcortical section of the brain. The device won 510(k) clearance from […]
Nico Corp. said it raised $15 million of a hoped-for $18 million funding round, led by prior backers River Cities Capital Funds and the Rose-Hulman Institute of Technology, for its BrainPath neurosurgery device. Indianapolis-based Nico said in a regulatory filing that 41 investors participated in the round, which nearly doubled its previous fundraising efforts. The BrainPath […]
Neurological device maker NICO and Hitachi (NYSE:HIT) said they are collaborating to create an ultrasound probe to aid in brain tumor operations using Nico’s BrainPath device. Hitachi’s Aloka ultrasound probe, which is still being developed, will be usable with Nico’s BrainPath device to allow operators better visualization of the location, size, and proximity of vessels during […]
Mazor Robotics Ltd. (TASE:MZOR) unveiled its new Renaissance device, the next generation of its spinal robotic surgical guidance systems technology, which extend potential applications to more complex spine surgeries.
The new system is built on the core of the previous generation SpineAssist technology, which has been successfully used in more than 2,000 surgeries worldwide, accurately placing more than 12,000 implants, according to company officials.